Dualyx
Ghent
About Dualyx
Dualyx engages in the discovery and development of biologicals for the treatment of autoimmune and rare diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $43.5M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2023)
- Website: dualyx.com
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/dualyx-107731 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.